October 5, 2021
Medical Disposables & Supplies Limited (MDS) Chief Financial Officer Mr. Raymond Ernandez highlighted the company’s financial performance over the last five years. MDS’ revenue as at March 31, 2021, totalled $2.42 billion compared to $2.48 billion recorded for the same period of the prior financial year, representing a 2% decrease year over year. Net profit for the period amounted to $69.61 million, 101% increase over the $34.56 million reported in the prior year. Mr. Ernandez stated, “we sold less but made more. We used covid as a year to rebalance the business technology and operation as a result of an increase in expenses.”
The Company’s Total Assets increased by 31% to $2.29 billion from $1.74 billion in the prior year, while Shareholders’ Equity as at March 31, 2021 amounted to $1.02 billion relative to $833.76 million in 2020, indicating a 22% increase. For the three months ended June 30, 2021, revenue totalled $682.58 million compared to the $510.08 million recorded for the same period of the prior financial year; this represents a 34% increase year over year. Net profit ended the quarter at $25.48 million relative to a loss of $7.07 million reported a year prior.
According to the Group’s Chief Executive Officer, Mr. Kurt Boothe, “not because we are a health center means we are immune to the impact of the pandemic, however, we used this downtime for preparation and an opportunity to focus on expansion. As such, “we have expanded our portfolio with the expectation of a great return in the next three years and extended our reach in other channels like the supermarket chains in addition to the traditional chains. We are also on the path of diversifying our products, these changes is in keeping with our aim to be a full-service distributor, not only confined to the health center.”
Mr. Boothe also added, “We expected to break even in nine months but we did it in eight. The Company is still focused on its’ expansion drive as we won our first negotiation deal.” MDS is currently celebrating its first acquisition of Cornwall Medical and Dental Supplies Limited. “Shifting from our friendly rivals to business partners through an acquisition deal in which we hold a 60% stake in our newly formed subsidiary, Cornwall Enterprises Limited,” noted Mr. Boothe. Moreover, “this succession blended well with our need for expansion. Cornwall’s two locations also benefit the company’s growth strategy to reach more customers and increase market share in the medical division.”
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein